Puma Biotechnology (PBYI) Cash from Operations Growth (1y) (2012 - 2026)
Puma Biotechnology (PBYI) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
326.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
326.36% |
| Dec 31, 2025 |
-7.62% |
| Sep 30, 2025 |
-12.22% |
| Jun 30, 2025 |
1,271.18% |
| Mar 31, 2025 |
-67.88% |
| Dec 31, 2024 |
49.28% |
| Sep 30, 2024 |
3.98% |
| Jun 30, 2024 |
-68.84% |
| Mar 31, 2024 |
325.50% |
| Dec 31, 2023 |
36.08% |
| Sep 30, 2023 |
-38.50% |
| Jun 30, 2023 |
123.76% |
| Mar 31, 2023 |
109.83% |
| Dec 31, 2022 |
241.36% |
| Sep 30, 2022 |
64.40% |
| Jun 30, 2022 |
-18,648.65% |
| Mar 31, 2022 |
-271.73% |
| Dec 31, 2021 |
3.55% |
| Sep 30, 2021 |
510.35% |
| Jun 30, 2021 |
-100.46% |
